Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis - PubMed (original) (raw)

. 1991 Jan;138(1):129-40.

Affiliations

• PMID: 1702929
• PMCID: PMC1886036

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis

B J Nickoloff et al. Am J Pathol. 1991 Jan.

Abstract

The importance of immunologic mechanisms in psoriasis has been deduced from the ability of immunosuppressive therapies to ameliorate this common and chronic skin disease. Certainly the histology of psoriatic lesions suggests a dialogue between the hyperplastic keratinocytes and infiltrating T lymphocytes and macrophages. To begin dissecting the cytokine network involved in the pathophysiology of psoriasis, the location, in both epidermal and dermal compartments, of tumor necrosis factor-alpha, interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha at the protein and/or mRNA levels were identified. Tumor necrosis factor-alpha was selected as a potentially key regulatory cytokine, first because it induces cultured keratinocyte interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha production, and second because intercellular adhesion molecule-1 expression by keratinocytes in psoriatic epidermis had been identified previously. Using immunohistochemical localization, tumor necrosis factor-alpha was identified in 12 psoriatic lesions as intense and diffuse expression by dermal dendrocytes (macrophages) in the papillary dermis (without significant staining of endothelial cells, mast cells, or dermal Langerhans cells), and focally by keratinocytes and intraepidermal Langerhans cells. Functional interaction between the dermal dendrocytes and keratinocytes was suggested by the presence of interleukin-8 expression of suprabasal keratinocytes immediately above the tumor necrosis factor-alpha-positive dermal dendrocytes. Interleukin-8 mRNA and transforming growth factor-alpha mRNA were detectable in the epidermal roof of psoriatic lesions, but neither was detectable at the protein or mRNA levels in any normal skin specimens. Treatment of cultured human keratinocytes with phorbol ester (which experimentally produces psoriasiform changes on mouse skin) or tumor necrosis factor-alpha also increased interleukin-8 and transforming growth factor-alpha mRNAs. Further elucidation of the cellular and molecular basis for the genesis and evolution of psoriasis will provide the framework for a better evaluation of the cause and treatment of this skin disease.

PubMed Disclaimer

Similar articles

• The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
  Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T. Yoshida A, et al. Arch Dermatol Res. 2008 Jan;300(1):37-45. doi: 10.1007/s00403-007-0809-y. Epub 2007 Oct 25. Arch Dermatol Res. 2008. PMID: 17960400
• Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.
  Nickoloff BJ, Naidu Y. Nickoloff BJ, et al. J Am Acad Dermatol. 1994 Apr;30(4):535-46. doi: 10.1016/s0190-9622(94)70059-1. J Am Acad Dermatol. 1994. PMID: 7512582
• Altered expression of keratinocyte growth factor and its receptor in psoriasis.
  Finch PW, Murphy F, Cardinale I, Krueger JG. Finch PW, et al. Am J Pathol. 1997 Dec;151(6):1619-28. Am J Pathol. 1997. PMID: 9403712 Free PMC article.
• Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
  Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Bata-Csorgo Z, et al. J Invest Dermatol. 1995 Jul;105(1 Suppl):89S-94S. doi: 10.1111/1523-1747.ep12316121. J Invest Dermatol. 1995. PMID: 7616005 Review.

Cited by

• Current concepts in the pathogenesis of psoriasis.
  Das RP, Jain AK, Ramesh V. Das RP, et al. Indian J Dermatol. 2009;54(1):7-12. doi: 10.4103/0019-5154.48977. Indian J Dermatol. 2009. PMID: 20049260 Free PMC article.
• Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
  Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V. Bruch-Gerharz D, et al. Am J Pathol. 2003 Jan;162(1):203-11. doi: 10.1016/S0002-9440(10)63811-4. Am J Pathol. 2003. PMID: 12507903 Free PMC article.
• IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy.
  Lemster BH, Carroll PB, Rilo HR, Johnson N, Nikaein A, Thomson AW. Lemster BH, et al. Clin Exp Immunol. 1995 Feb;99(2):148-54. doi: 10.1111/j.1365-2249.1995.tb05525.x. Clin Exp Immunol. 1995. PMID: 7531627 Free PMC article. Clinical Trial.
• The skin immune system and psoriasis.
  Breathnach SM. Breathnach SM. Clin Exp Immunol. 1993 Mar;91(3):343-5. doi: 10.1111/j.1365-2249.1993.tb05906.x. Clin Exp Immunol. 1993. PMID: 8443957 Free PMC article. Review. No abstract available.
• Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster.
  Wong DT, Donoff RB, Yang J, Song BZ, Matossian K, Nagura N, Elovic A, McBride J, Gallagher G, Todd R, et al. Wong DT, et al. Am J Pathol. 1993 Jul;143(1):130-42. Am J Pathol. 1993. PMID: 8317544 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9175-9 - PubMed
2. 1. J Biol Chem. 1989 Mar 25;264(9):5164-71 - PubMed
3. 1. Am J Pathol. 1990 Jan;136(1):103-10 - PubMed
4. 1. J Immunol. 1990 May 15;144(10):3822-8 - PubMed
5. 1. J Clin Invest. 1990 Feb;85(2):605-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information